by Buck Institute
April 10, 2020 . News
WEBINAR SERIES: Conversations at the Buck, The COVID-19 Pandemic
We hope you enjoyed our COVID-19 Webinar series in April and May. Part 2 began June 10th with Matt Willis, Marin County Public Health Officer. Click below to register to view upcoming sessions and archived sessions. If you already registered for the last webinar series, you do not have to register again. Join our mailing list (bottom of the page) to stay up to date on our latest news and events.
Day of sessions: Go to the webinar site to start viewing the session. No log in or password required.
The Buck is the world’s premier scientific research institute focused solely on the biology of aging. For more than 20 years our mission has been to end the threat of age-related disease to help people live better longer. Because the novel coronavirus disproportionately impacts adults over 60 we know that our expertise is critical, and that is why we have refocused the work of many of our labs to join the fight against COVID-19.
During this time of disruption, we are eager to lean into our scientific expertise to fight this virus – a fight which includes a commitment to provide the public with evidence-based information on health and disease.
We have a network of colleagues both inside and outside of the Buck who have important perspectives on how to think about, deal with, and potentially treat this pandemic. We feel privileged to be able to share their insights with you in a special web series focused on COVID-19.
We have been speaking to leaders in health care, epidemiology, and molecular biology to bring an array of perspectives to this global health crisis. We hope you can join us for our next webinar series in June.
Register once and get access to every upcoming conversation.
Science is showing that while chronological aging is inevitable, biological aging is malleable. There's a part of it that you can fight, and we are getting closer and closer to winning that fight.
Eric Verdin, MD, Buck Institute President and CEO